Product Theaters:
Don’t miss the convenient opportunity to learn about new research, product information, technology demonstrations and more at the mini-theaters located in the Exhibit Hall. Seating is first-come, first-served.
Monday, March 30, 2026 – 12:15 - 1:15 p.m. | Southwest Product TheaterExploring the Risk Reduction in Thrombosis
Tomas Villanueva, DO, MBA, FACPE, SFHM, Chief of Primary Care & Hospital Medicine,0Baptist Health Medical Group, part of Baptist Health South Florida, Miami, Florida
Sponsored by Janssen Pharmaceuticals, Inc.
Monday, March 30, 2026 – 12:15 - 1:15 p.m. | Northwest Product Theater
Opioid-Induced Constipation: When Reliable and Rapid Relief Matters
Naum Shaparin, MD, Montefiore Medical Center, Bronx, New York
Sponsored by Salix Pharmaceuticals, Inc.
Monday, March 30, 2026 – 12:15 - 1:15 p.m. | Northeast Product Theater
A Nebulized Long-Acting Beta2-Agonist for the Maintenance Treatment of COPD: Who, When, and Why?
Israel Rubinstein, MD, Professor of Medicine, Division of Pulmonary, Critical Care, Sleep and Allergy Medicine, University of Illinois at Chicago, Chicago, Illinois
Sponsored by Mylan Specialty, LP
Monday, March 30, 2026 – 5:30 - 6:30 p.m. | Southwest Product Theater
Treatment Pathways for Patients on DALVANCE Therapy
Speaker information coming soon
Sponsored by Actavis Pharma, Inc.
Monday, March 30, 2026 – 5:30 - 6:30 p.m. | Northwest Product Theater
The Evolving Management of Acute Bacterial Skin and Skin Structure Infections; from ED to Hospital or Not?
Charles V. Pollack, MD, Chair, Department of Emergency Medicine, Pennsylvania Hospital, Professor of Emergency Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
Daniel M. Perlman, MD, Hospitalist/Infectious Disease Specialist, Medical Director, Heart of the Rockies Regional Medical Center, Salida, Colorado
Christopher Lucasti, MD, Chairman, Infection Control Department, Shore Medical Center, Somers Point, New Jersey
Sponsored by The Medicines Company.
Monday, March 30, 2026 – 5:30 - 6:30 p.m. | Northeast Product Theater
Diagnosis and Management of Atrial Fibrillation: Working Together to Reduce Stroke Risk in NVAF
David J. Cohen, MD, MSc, Saint Luke’s Mid American Heart Institute, University of Missouri, Kansas City, Missouri
Ilyas K. Colombowala, MD, Rocky Mountain Heart and Lung of Kalispell Regional, Kalispell, Montana
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Medtronic
Tuesday, March 31, 2026 – 12:15 - 1:15 p.m. | Southwest Product Theater
Hepatic Encephalopathy: Understanding the CNS Dysfunction as a Result of Cirrhosis
Steven Flamm, MD, Chief, Liver Transplantation, Northwestern Memorial Hospital, Professor of Medicine & Surgery, Northwestern University, Feinberg School of Medicine, Chicago, Illinois
Sponsored by Salix Pharmaceuticals, Inc.
Tuesday, March 31, 2026 – 12:15 - 1:15 p.m. | Northwest Product Theater
Discussion of an Anticoagulant for Treatment of Nonvalvular Atrial Fibrillation and Venous Thromboembolism
Scott Kaatz, DO, MSc, FACP, FHM, Chief Quality Officer, Hurley Medical Center, Clinical Associate Professor of Medicine, Michigan State University College of Human Science
Sponsored by Daiichi Sankyo, Inc.
Tuesday, March 31, 2026 – 12:15 - 1:15 p.m. | Northeast
Product Theater Treating Venous Thrombosis (VTE) and Reducing the Risk of Stroke in Nonvalvular Atrial Fibrillation (NVAF)
John H. Lawrence, MD, Vice President, Cardiovascular Specialty Development, Development Lead, Apixaban, Bristol-Myers Squibb Company
Sponsored by Bristol-Myers Squibb/Pfizer.
| Tweet |
|